Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Mar;8(1):21-5.
doi: 10.4142/jvs.2007.8.1.21.

Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves

Affiliations
Comparative Study

Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves

Neetu Rajput et al. J Vet Sci. 2007 Mar.

Abstract

We investigated the disposition kinetics and urinary excretion of cefpirome in buffalo calves after a single intravenous administration of 10 mg/kg. Also, an appropriate dosage regimen was calculated. At 1 min after injection, the concentration of cefpirome in the plasma was 57.4 +/- 0.72 microg/ml, which declined to 0.22 +/- 0.01 microg/ml at 24 h. The cefpirome was rapidly distributed from the blood to the tissue compartment as shown by the high distribution coefficient values (8.67 +/- 0.46/h), and by the drug's rate of transfer constant from the central to the peripheral compartment, K(12) (4.94 +/- 0.31/h). The elimination halflife and the volume of distribution were 2.14 +/- 0.02 h and 0.42 +/- 0.005 l/kg, respectively. Once the distribution equilibrium was reached between the tissues and plasma, the total body clearance (Cl(B)) and the ratio of the drug present in the peripheral to the central compartment (T/P ratio) were 0.14 +/- 0.002 l/kg/h and 1.73 +/- 0.06, respectively. Based on the pharmacokinetic parameters we obtained, an appropriate intravenous cefpirome dosage regimen for treating cefpiromesensitive bacteria in buffalo calves would be 8.0 mg/kg repeated at 12 h intervals for 5 days, or until persistence of the bacterial infection occurred.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Semilogarithmic plot of the plasma concentration-time profile of cefpirome in buffalo calves following a single intravenous dose of 10 mg/kg body weight. Values given are mean ± SE of 5 animals. The data were analyzed using a two-compartment open model. Distribution (α) and elimination (β) phases are represented by least-square regression lines. The calculated points (o) of the distribution phase were obtained by the feathering off technique.

Similar articles

References

    1. Arai S, Kobayashi S, Hayashi S, Sakaguchi T. Distribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch. Antimicrob Agents Chemother. 1988;32:1396–1399. - PMC - PubMed
    1. Arret B, Johnson DP, Kirshbaum A. Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci. 1971;60:1689–1694. - PubMed
    1. Bertram MA, Bruckner DA, Young LS. In vitro activity of HR 810, a new cephalosporin. Antimicrob Agents Chemother. 1984;26:277–279. - PMC - PubMed
    1. Dardi MS, Sharma SK, Srivastava AK. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves. Vet Res Commun. 2004;28:331–338. - PubMed
    1. Gardner SY, Papich MG. Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs. J Vet Pharmacol Ther. 2001;24:187–192. - PubMed

Publication types